Danish Cancer Patients to Receive State-of-the-Art Radiotherapy Treatments with New Varian Equipment at Three Hospitals
May 16 2007 - 4:59AM
PR Newswire (US)
COPENHAGEN/HERLEV, Denmark, May 16 /PRNewswire-FirstCall/ -- Cancer
patients in Denmark will benefit from state-of-the-art radiotherapy
treatments with the installation of new suites of treatment
machines, software and networking systems from Varian Medical
Systems, the world leader in radiotherapy. After a much anticipated
decision announced and orders placed in March, radiotherapy centers
in Herlev, Copenhagen and Naestved will receive 14 new Varian
linear accelerators, each complete with accessories and software
enabling Intensity Modulated Radiation Therapy (IMRT) and Image
Guided Radiation Therapy (IGRT), over the next 18 months. The new
equipment, to be installed at Herlev Hospital and Rigshospitalet in
Copenhagen, both in the Capital Region, and Hospital South in
Naestved, in the Region of Zealand, will enable the three centers
to extend their Intensity Modulated Radiation Therapy (IMRT) and
Image Guided Radiation Therapy (IGRT) programs. Varian's latest
Eclipse(TM) treatment planning and ARIA(TM) information management
software will be installed at all three sites, providing the three
clinics with an integrated network for fast efficient treatments
that minimize patient waiting times. All the new Clinac(R) linear
accelerators -- eight at Herlev, four at Rigshospitalet and two at
Naestved -- will come equipped with the On-Board Imager(R) device
for modern, real-time image guidance. IGRT enables clinicians to
pinpoint the position of the tumor at the time of treatment,
allowing more precise treatments and potentially fewer side
effects. When the new accelerators are installed, Rigshospitalet
will have 13 Varian treatment machines, making it one of the
largest radiotherapy centers in Europe. Naestved Hospital, in
co-operation with Rigshospitalet, serves patients in the south of
the Zealand region and will act as a key part of the integrated
approach planned for the three cancer centers. Dr. Peter Michael
Vestlev, head of radiotherapy at Herlev Hospital, said the clinic's
IGRT program will advance the precision and quality of cancer
treatments. "We are also very much looking forward to integrating
the new software systems," he added, "so we can have just one data
system for tracking and treating patients." He said the
department's seven existing accelerators, one of which is 19 years
old, would be replaced over time by the new equipment. Herlev
Hospital carries out 40,000 radiation treatments per annum,
treating 2,500 new patients each year. Sten Hornsleth, Varian's
Scandinavian regional manager, said, "This major investment shows
the commitment of the Danish government to improving cancer care
and will bring the latest in radiotherapy treatments to the
country's cancer patients. We are delighted that Varian was
selected to equip these projects and we look forward to providing
clinicians at all three hospitals with the tools to treat their
patients as precisely and effectively as possible." Editorial
contact: Neil Madle, Varian Medical Systems, +44 7786 526068, About
Varian Medical Systems Varian Medical Systems, Inc., of Palo Alto,
California, is the world's leading manufacturer of medical devices
and software for treating cancer and other medical conditions with
radiotherapy, radiosurgery, proton therapy, and brachytherapy. The
company supplies informatics software for managing comprehensive
cancer clinics, radiotherapy centers and medical oncology
practices. Varian is a premier supplier of tubes and digital
detectors for X-ray imaging in medical, scientific, and industrial
applications and also supplies X-ray imaging products for cargo
screening and industrial inspection. Varian Medical Systems employs
approximately 4,200 people who are located at manufacturing sites
in North America and Europe and in its 56 sales and support offices
around the world. In Europe, the company operates manufacturing and
engineering centers in Baden (Switzerland), Crawley (England), Haan
(Germany), Helsinki (Finland) and Toulouse (France) and has
headquarters for Europe, Middle East, India and Africa (EMEA) based
in Zug, Switzerland. For more information, visit
http://www.varian.com/. Forward Looking Statements Statements in
this press release regarding future business, events, plans,
objectives, expectations, estimates, and other similar matters,
including, but not limited to, statements using the terms "can" and
"expect," constitute forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. Such
forward-looking statements contained in this press release are
subject to risks and uncertainties that could cause actual results
to differ materially from those anticipated, including, but not
limited to, the risks described in the company's Annual Report on
Form 10-K and other reports filed from time to time by the Company
with the Securities and Exchange Commission. These forward-looking
statements represent the Company's judgment as of the date of this
press release. The Company assumes no obligation to update or
revise these forward-looking statements because of new information,
future events, or otherwise. DATASOURCE: Varian Medical Systems,
Inc. CONTACT: Neil Madle of Varian Medical Systems,
+44-7786-526068, Web site: http://www.varian.com/
Copyright